Search results

• Supporting the next generation of therapeutic vaccines

  Vaccine adjuvants are used to enhance immune response to an antigen, improving the overall efficacy of the vaccine and increasing protection against the target disease.

• Collaboration to develop alternative vaccine adjuvants

  In 2021 we established a strategic collaboration with the Danish Government’s life science research institute, Statens Serum Institute (SSI).

• Investors

  Investor information including financial reporting and events.

• Investor seminar on our Life Sciences sector

  7 October 2019: Senior members of our management team provided a comprehensive overview of the Life Sciences sector, with a particular focus on our Health Care business.

• Finance review 2025

  “With a comprehensive transformation programme that is driving both growth and efficiencies, we are firmly focused on execution. Progress so far has been encouraging, and we are setting out a financial framework to full year 2028 that outlines further improvements in financial performance.”

• Industrial Specialties business review

  Discover how Industrial Specialties is enabling continued growth, exploring innovation, market trends, and strategic growth driving performance in this year’s annual report business review.

• Consumer Care sustainability review

  Connecting sustainability to people, making it personal, is core to the sustainability focus within the Consumer Care business. Consumers desire personal care products that deliver performance, without negatively impacting the planet. Keeping this at the core creates value for our customers’ brands and the consumers they serve.

• Sustainability Progress Statement

  Explore our 2025 Sustainability Progress Statement to see how we’re driving measurable progress on climate action, responsible sourcing, and social impact, creating sustainable solutions that deliver lasting value for our customers, communities, and the planet.

• Climate Positive

  By 2030, we will be Climate Positive.

• Acquisitions

  Commercialising and increasing our access to new ideas and technologies.

• Regulatory news

  Our most recent announcements to the stock exchange.

• About us

  We are the name behind high performance ingredients and technologies in some of the most successful brands in the world.

• EMEA

  Our global headquarters are based in Yorkshire in the UK. We also have a number of offices and manufacturing sites spread across the region.

• USA

  Croda Inc is the North American headquarters for Croda, with over 800 employees, working in a variety of roles in manufacturing, sales, marketing and research and development.

• North America

  Croda Inc is the North American headquarters for Croda, we have four manufacturing sites, four innovation centres and four sales hubs in the region.

• UK Pensions

  Explore information on Croda UK pensions, including state pensions, workplace schemes, death benefits and retirement.

• People Positive

  By 2030, we will be People Positive.

• Chief Executive sustainability statement

  “By thinking boldly, acting with purpose, and living our values every day, we are bringing Smart science to improve lives™ to life and working hard to achieve our commitment to be the most sustainable supplier of innovative ingredients by 2030, delivering solutions to tackle some of the world’s biggest challenges”

• Media coverage Page Summary Title

  Media coverage Page Summary Description

• Croda launches animated timeline to showcase 100 years of innovation

  13 February 2025: Croda today launches an animated historical timeline to mark its centenary year.